FDA approves Glenmark’s generic Lotrisone

SILVER SPRING, Md. — The Food and Drug Administration has approved Glenmark Pharmaceuticals’ generic of Lotrisone (betamethasone dipropionate) cream, the company announced Monday. 

 

The cream is indicated to treat such fungal infections as athlete’s foot and ringworm, among others. U.S. sales for the drug in the 12 months ending in September were $82.4 million.